2021 KL2 Scholar RFA NOW OPEN
TRI is now accepting applications for the 2021 CTSA Funded KL2 Scholar Awards. An additional Cancer Research Institutional Scholar Award is also available for 2021.More Information
The overall goal of the TRI Career Development Scholars Program is to increase the number and quality of independently funded clinical and translational research investigators.
TRI Scholar Awards provide two years of didactic and mentored research training for postdoctorates or professional doctorates (M.D., Pharm.D., Dr.PH., D.O., etc.) who are committed to academic careers in multidisciplinary clinical or translational research. Didactic course work leading to an additional Ph.D., M.S., M.P.H. or graduate certificate may be pursued. Generous financial support and benefits are provided for junior faculty.
The Program has two types of scholars: KL2 career development scholars and institutional career development scholars. KL2 Scholars receive their funding through and are affiliated with the CTSA’s KL2 Mentored Research Career Development Scholar Award Program. Institutional Scholars receive their funding from institutional sources and are not officially affiliated with the CTSA’s KL2 Program. Both types of scholars undergo the same application process, must adhere to the same requirements, and receive the same benefits.
Salary and Benefits
- 75 percent of the scholar’s salary (up to $95,000, including fringe). If 75 percent salary exceeds $95,000, the college/department/division will need to support the balance.
- Up to $25,000 per year for research, tuition, travel expenses and education materials in support of the scholar’s career development plan.
- A doctoral-level degree in a health discipline that can be applied to clinical or translational research. These degrees include, but are not limited to, M.D., Ph.D., Pharm.D., Dr.PH., or D.O.
- Must be a United States citizen, non-citizen national or permanent resident. Individuals on temporary or student visas are not eligible.
- Must be committed to a career focused on clinical or translational investigation.
- Must be a full-time UAMS faculty member at the rank of instructor or above, able to devote 75 percent professional effort to the program for a minimum of two years.
- Must have the support of a mentor approved by the program, and the approval of their department chair.
- Candidates are not allowed to have served as principal investigator on a National Institutes of Health (NIH) R01, K series or sub project of a P or M series grant.